
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding Corp demonstrates a robust growth trajectory, achieving a compound annual growth rate (CAGR) of 16% in revenue since 2022, driven by significant gains in both subscription and volume-based revenue streams. The company's platform, which enhances operational efficiencies for healthcare providers, has resulted in a notable increase in the share of high-value customers, recording a quarter-over-quarter growth rate of 3.4% in 1Q25. Additionally, the firm's expansion in the ambulatory sector, coupled with increasing channel partner fees that reflect strong market engagement, underscores the positive outlook for Waystar's financial performance moving forward.
Bears say
The financial outlook for Waystar Holding Corp appears negative due to several concerning metrics. Capital expenditures as a percentage of revenue decreased from previous years, indicating potential inefficiencies, while revenue is projected to decline sequentially in the third quarter and remain flat in the fourth quarter. Additionally, a significant drop in EBITDA and the ramifications of a cyberattack on Change Healthcare highlight vulnerabilities that could undermine client trust and revenue growth.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares